7/102 sources · 2 publishersUpdated Nov 11, 16:46 UTC
Piper Sandler upgrades Alpha Tau Medical to Overweight and lifts price target
Piper Sandler raised its rating on Alpha Tau Medical to Overweight, moving it up from Neutral. The firm also increased its price target to $22, up from $8, a 175% jump. The upgrade was driven by expected oncology catalysts over the next year, according to analyst Allison Bratzel. The stock rallied on the news.
Why it matters
The new $22 target suggests the analyst sees significant upside potential, but it still implies a 99.5% downside from the closing price of $4,515, indicating the market may be overvalued in the short term. Investors will watch whether the anticipated oncology milestones materialize.
Key facts
- 1Piper Sandler changed its rating on Alpha Tau Medical to Overweight from Neutral. tradingview.com
- 2The firm raised its price target to $22, up from $8, a 175% increase. tradingview.com
- 3The upgrade cites expected oncology therapeutic catalysts over the next year. seekingalpha.com
- 4The new target of $22 implies a 99.5% downside from the November 11 close of $4,515. tradingview.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.